News
London: British pharmaceutical giant AstraZeneca has paused a planned 200 million ($271 million) expansion of its research site in Cambridge, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback